LeMaitre Vascular (NASDAQ:LMAT) Releases FY24 Earnings Guidance

LeMaitre Vascular (NASDAQ:LMAT) issued an update on its FY24 earnings guidance on Thursday morning. The company provided earnings per share guidance of $1.91 to $1.96 for the period, compared to the consensus earnings per share estimate of $1.85. The company issued revenue guidance of $219.0 million to $221.0 million, compared to the consensus revenue estimate of $218.32 million. LeMaitre Vascular also updated its FY 2024 guidance to 1.910-1.960 EPS.

LeMaitre Vascular Stock Performance

Shares of LMAT stock traded up $6.49 on Friday, hitting $94.88. 343,645 shares of the stock traded hands, compared to its average volume of 105,134. LeMaitre Vascular has a twelve month low of $45.96 and a twelve month high of $101.67. The firm’s 50-day moving average price is $89.59 and its two-hundred day moving average price is $83.25. The stock has a market capitalization of $2.13 billion, a PE ratio of 51.85, a PEG ratio of 2.32 and a beta of 0.89.

LeMaitre Vascular (NASDAQ:LMAT) last posted its earnings results on Thursday, October 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.44 by $0.05. The company had revenue of $54.82 million for the quarter, compared to analyst estimates of $53.50 million. LeMaitre Vascular had a net margin of 19.40% and a return on equity of 13.39%. LeMaitre Vascular’s revenue was up 15.6% on a year-over-year basis. During the same period in the previous year, the business posted $0.33 EPS. On average, equities research analysts anticipate that LeMaitre Vascular will post 1.86 EPS for the current fiscal year.

LeMaitre Vascular Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 5th. Shareholders of record on Thursday, November 21st will be given a $0.16 dividend. The ex-dividend date of this dividend is Thursday, November 21st. This represents a $0.64 dividend on an annualized basis and a yield of 0.67%. LeMaitre Vascular’s dividend payout ratio is currently 34.97%.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on LMAT shares. Oppenheimer reiterated an “outperform” rating and set a $93.00 price target (up from $90.00) on shares of LeMaitre Vascular in a report on Friday. JMP Securities increased their target price on shares of LeMaitre Vascular from $77.00 to $100.00 and gave the stock a “market outperform” rating in a research note on Tuesday, August 20th. Barrington Research boosted their price target on shares of LeMaitre Vascular from $92.00 to $93.00 and gave the company an “outperform” rating in a research note on Friday. StockNews.com lowered shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a report on Tuesday, August 27th. Finally, Cantor Fitzgerald initiated coverage on shares of LeMaitre Vascular in a report on Tuesday, October 15th. They issued a “neutral” rating and a $96.00 target price for the company. Three analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, LeMaitre Vascular has a consensus rating of “Moderate Buy” and an average target price of $94.57.

Insider Activity

In other LeMaitre Vascular news, Director David B. Roberts sold 3,063 shares of the stock in a transaction dated Tuesday, August 13th. The stock was sold at an average price of $82.07, for a total value of $251,380.41. Following the sale, the director now owns 14,114 shares of the company’s stock, valued at $1,158,335.98. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 10.79% of the company’s stock.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.